CS410591A3 - Novel quaternary 6,11-dihydrodibenzo/b, e/thiepin-11-alkyl-norshopin ethers, process of their preparation and pharmaceuticals containing them - Google Patents

Novel quaternary 6,11-dihydrodibenzo/b, e/thiepin-11-alkyl-norshopin ethers, process of their preparation and pharmaceuticals containing them

Info

Publication number
CS410591A3
CS410591A3 CS914105A CS410591A CS410591A3 CS 410591 A3 CS410591 A3 CS 410591A3 CS 914105 A CS914105 A CS 914105A CS 410591 A CS410591 A CS 410591A CS 410591 A3 CS410591 A3 CS 410591A3
Authority
CS
Czechoslovakia
Prior art keywords
preparation
ethers
norshopin
thiepin
dihydrodibenzo
Prior art date
Application number
CS914105A
Other languages
English (en)
Inventor
Rolf Dr Banholzer
Rudolf Dr Bauer
Original Assignee
Boehringer Ingelheim Kg
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg, Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Kg
Publication of CS410591A3 publication Critical patent/CS410591A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/08—Diarylmethoxy radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS914105A 1982-03-26 1991-12-27 Novel quaternary 6,11-dihydrodibenzo/b, e/thiepin-11-alkyl-norshopin ethers, process of their preparation and pharmaceuticals containing them CS410591A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823211185 DE3211185A1 (de) 1982-03-26 1982-03-26 Neue quartaere 6,11-dihydro-dibenzo-(b,e)-thiepin-11-n-alkyl- norscopinether und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
CS410591A3 true CS410591A3 (en) 1992-06-17

Family

ID=6159392

Family Applications (2)

Application Number Title Priority Date Filing Date
CS832040A CS236790B2 (en) 1982-03-26 1983-03-24 Processing of new quartery 6,uu-dihydrodibenzo(b,e)thiepin-11-n-alkyl-norskpinether
CS914105A CS410591A3 (en) 1982-03-26 1991-12-27 Novel quaternary 6,11-dihydrodibenzo/b, e/thiepin-11-alkyl-norshopin ethers, process of their preparation and pharmaceuticals containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS832040A CS236790B2 (en) 1982-03-26 1983-03-24 Processing of new quartery 6,uu-dihydrodibenzo(b,e)thiepin-11-n-alkyl-norskpinether

Country Status (25)

Country Link
US (1) US4608377A (cs)
EP (1) EP0090195B1 (cs)
JP (1) JPS58174380A (cs)
KR (1) KR900004143B1 (cs)
AT (1) ATE16591T1 (cs)
AU (1) AU554262B2 (cs)
CA (1) CA1254564A (cs)
CS (2) CS236790B2 (cs)
DD (2) DD210276A5 (cs)
DE (2) DE3211185A1 (cs)
DK (1) DK164703C (cs)
ES (2) ES8402290A1 (cs)
FI (1) FI73995C (cs)
GR (1) GR77437B (cs)
HU (1) HU189675B (cs)
IE (1) IE55110B1 (cs)
IL (1) IL68230A0 (cs)
NO (1) NO158741C (cs)
NZ (1) NZ203696A (cs)
PH (1) PH20502A (cs)
PL (1) PL138982B1 (cs)
PT (1) PT76420B (cs)
SU (1) SU1144618A3 (cs)
YU (1) YU42847B (cs)
ZA (1) ZA832135B (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3215493A1 (de) * 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neue zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung
DE3215490A1 (de) * 1982-04-26 1983-11-03 Boehringer Ingelheim KG, 6507 Ingelheim Neues vorprodukt, verfahren zu seiner herstellung und seine verwendung
HUP0300832A2 (hu) * 2000-04-27 2003-08-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
EP1292281B1 (de) * 2000-10-12 2004-09-08 Boehringer Ingelheim Pharma GmbH & Co.KG Neue tiotropium-haltige inhalationspulver
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
US6852728B2 (en) 2000-10-14 2005-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020111363A1 (en) * 2000-10-31 2002-08-15 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
US20030013675A1 (en) * 2001-05-25 2003-01-16 Boehringer Ingelheim Pharma Kg Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
DE10200943A1 (de) 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
US7405224B2 (en) * 2002-01-31 2008-07-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7311894B2 (en) * 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
NZ536277A (en) * 2002-04-04 2006-03-31 Boehringer Ingelheim Pharma Powder formulations containing tiotropium suitable for inhalation
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
US20080051582A1 (en) * 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1102167B (de) * 1957-09-26 1961-03-16 Sandoz Ag Verfahren zur Herstellung von Scopinaethern
CH476015A (de) * 1965-06-28 1969-07-31 Sandoz Ag Verfahren zur Herstellung neuer Tropanäther
CH582699A5 (cs) * 1973-03-26 1976-12-15 Sandoz Ag

Also Published As

Publication number Publication date
EP0090195B1 (de) 1985-11-21
YU42847B (en) 1988-12-31
DK164703C (da) 1992-12-21
AU1286683A (en) 1983-09-29
NO158741C (no) 1988-10-26
ES520985A0 (es) 1984-01-16
CS236790B2 (en) 1985-05-15
EP0090195A1 (de) 1983-10-05
PL241175A1 (en) 1984-01-30
PL138982B1 (en) 1986-11-29
DK94783A (da) 1983-09-27
NO158741B (no) 1988-07-18
NO831084L (no) 1983-09-27
KR900004143B1 (ko) 1990-06-16
FI830979L (fi) 1983-09-27
DK164703B (da) 1992-08-03
HU189675B (en) 1986-07-28
IL68230A0 (en) 1983-06-15
PH20502A (en) 1987-01-21
DD210276A5 (de) 1984-06-06
JPS58174380A (ja) 1983-10-13
FI73995C (fi) 1987-12-10
ATE16591T1 (de) 1985-12-15
AU554262B2 (en) 1986-08-14
DK94783D0 (da) 1983-02-25
CA1254564A (en) 1989-05-23
PT76420B (pt) 1986-02-04
FI73995B (fi) 1987-08-31
IE830671L (en) 1983-09-26
US4608377A (en) 1986-08-26
YU70783A (en) 1985-12-31
ZA832135B (en) 1984-11-28
GR77437B (cs) 1984-09-14
SU1144618A3 (ru) 1985-03-07
NZ203696A (en) 1985-08-16
ES8402290A1 (es) 1984-01-16
DD215547A5 (de) 1984-11-14
ES8401971A1 (es) 1984-01-01
DE3361261D1 (en) 1986-01-02
JPH0358347B2 (cs) 1991-09-05
FI830979A0 (fi) 1983-03-23
ES520988A0 (es) 1984-01-01
DE3211185A1 (de) 1983-09-29
KR840004106A (ko) 1984-10-06
IE55110B1 (en) 1990-06-06
PT76420A (de) 1983-04-01

Similar Documents

Publication Publication Date Title
CS410591A3 (en) Novel quaternary 6,11-dihydrodibenzo/b, e/thiepin-11-alkyl-norshopin ethers, process of their preparation and pharmaceuticals containing them
DE3062467D1 (en) Process for the preparation of 4,1&#39;,6&#39;-trichloro-4,1&#39;,6&#39;-trideoxy-galactosucrose
IL70070A (en) Process for the preparation of(2,2)-paracyclophane
IL64292A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
DE3368627D1 (en) Process for the preparation of 8,12-epoxy-13,14,15,16-tetranor labdane
DE2966179D1 (en) Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same
IL57213A0 (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetra-hydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them
PT70537A (en) Process for the preparation of 2&#39;,6&#39;-dialkyl-n-alkoxymethyl-2-chloro-acetanilides
IL84955A0 (en) Novel carbamoyloxylabdanes,process for the preparation thereof and pharmaceutical compositions containing them
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
DE3360040D1 (en) Process for the preparation of 2,3-dichlorobutadiene-1,3
EP0033840A3 (en) Kijanimicin, pharmaceutical compositions containing it, micro-organisms capable of producing it and processes for preparing kijanimicin and the compositions
PT74400B (en) Process for the preparation of 17,18-dehydro-apovincaminol-3&#39;, 4&#39;,5&#39;-trimethoxy-benzoate and of pharmaceutical compositions containing them
DE3160815D1 (en) Process for the preparation of 2,6-dichlorobenzoxazole or 2,6-dichlorobenzthiazole
DE3369122D1 (en) Process for the preparation of 1,2-dichloroethane
DE3163774D1 (en) Process for the preparation of 5-amino-2,4 dimethylacetanilide
DE3160222D1 (en) Process for the preparation of 2,6-xylidine
IL69624A0 (en) 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl-isoquinolines and their preparation
DE3377217D1 (en) Process for the preparation of monobenzoylated 1,4-diaminoanthraquinones
DE3166701D1 (en) 3-amino-5-substituted-6-halo-n-(3,4-dihydro- or 4,4-disubstituted-6-substituted-1,3,5-triazin-2-yl)-2-pyrazinecarboxamides, process for preparing and pharmaceutical compositions containing the same
GB8314158D0 (en) Process for the preparation of 1,1-bisphenyl-2-haloalkan-1-ols
DE3066040D1 (en) Process for the preparation of 4,5-dinitro-1,8-dihydroxyanthraquinone
EP0087047A3 (en) Process for the preparation of n, and o, substituted urethanes